Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M410817200 on March 7, 2005

J. Biol. Chem., Vol. 280, Issue 20, 20010-20020, May 20, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/20/20010    most recent
M410817200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villafuerte, B. C.
Right arrow Articles by Kaytor, E. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villafuerte, B. C.
Right arrow Articles by Kaytor, E. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An Insulin-response Element-binding Protein That Ameliorates Hyperglycemia in Diabetes*{boxs}

Betty C. Villafuerte{ddagger}§ and Elizabeth N. Kaytor¶||

From the {ddagger}Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40202 and the Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322

Insulin modulates glucose homeostasis, but the role of insulin-responsive transcription factors in such actions is not well understood. Recently, we have identified the insulin-response element-binding protein-1 (IRE-BP1) as a transcription factor that appears to mediate insulin action on multiple target genes. To examine the possibility that IRE-BP1 is an insulin-responsive glucoregulatory factor involved in the metabolic actions of insulin, we investigated the effect of adenoviral overexpression of hepatic IRE-BP1 on the glycemic control of insulin-resistant diabetic rats. Adenoviral IRE-BP1 lowered both fasting and postprandial glucose levels, and microarray of hepatic RNA revealed modulation of the expression of genes involved in gluconeogenesis, lipogenesis, and fatty acid oxidation. The insulin mimetic effects of IRE-BP1 were also confirmed in L6 myocytes; stable constitutive expressions of IRE-BP1 enhanced glucose transporter expression, glucose uptake, and glycogen accumulation in these cells. These findings showed physiologic sufficiency of IRE-BP1 as the transcriptional mediator of the metabolic action of insulin. Understanding IRE-BP1 action should constitute a useful probe into the mechanisms of metabolic regulation and an important target to develop therapeutic agents that mimic or enhance insulin action.


Received for publication, September 20, 2004 , and in revised form, March 4, 2005.

* This work was supported by EmTech Biotechnology Development Inc., Georgia Institute of Technology Faculty Research Commercialization Program, and by the Walter F. and Avis Jacobs Foundation (to B. C. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains Supplement A.

|| Present address: Fish & Richardson PC, 60 South 6th St., 3300 Dain Rauscher Plaza, Minneapolis, MN 55402.

§ To whom correspondence should be addressed: Dept. of Medicine, Division of Endocrinology, University of Louisville School of Medicine, 570 S. Preston St., Donald Baxter Bldg., Rm. 221E, Louisville, KY 40202. Tel.: 502-852-4048; Fax: 502-852-2492; E-mail: bcvill01{at}louisville.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
B. C. Villafuerte, M. T. Barati, Y. Song, J. P. Moore, P. N. Epstein, and J. Portillo
Transgenic Expression of Insulin-Response Element Binding Protein-1 in {beta}-Cells Reproduces Type 2 Diabetes
Endocrinology, June 1, 2009; 150(6): 2611 - 2617.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Chahal, C.-C. Chen, M. J. Rane, J. P. Moore, M. T. Barati, Y. Song, and B. C. Villafuerte
Regulation of Insulin-Response Element Binding Protein-1 in Obesity and Diabetes: Potential Role in Impaired Insulin-Induced Gene Transcription
Endocrinology, October 1, 2008; 149(10): 4829 - 4836.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Majumdar, A. Harrington, J. Hungerford, A. Martinez-Hernandez, I. C. Gerling, R. Raghow, and S. Solomon
Insulin Dynamically Regulates Calmodulin Gene Expression by Sequential O-Glycosylation and Phosphorylation of Sp1 and Its Subcellular Compartmentalization in Liver Cells
J. Biol. Chem., February 10, 2006; 281(6): 3642 - 3650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement